Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.6 - $2.48 $19,747 - $30,608
-12,342 Reduced 5.71%
203,643 $502,000
Q3 2023

Nov 13, 2023

BUY
$1.55 - $3.31 $92,767 - $198,103
59,850 Added 38.33%
215,985 $516,000
Q2 2023

Aug 10, 2023

SELL
$1.52 - $2.78 $6,780 - $12,401
-4,461 Reduced 2.78%
156,135 $243,000
Q1 2023

May 11, 2023

SELL
$2.36 - $3.35 $42,111 - $59,777
-17,844 Reduced 10.0%
160,596 $406,000
Q4 2022

Feb 13, 2023

BUY
$2.58 - $4.68 $23,018 - $41,754
8,922 Added 5.26%
178,440 $480,000
Q3 2022

Nov 08, 2022

SELL
$2.7 - $4.3 $24,089 - $38,364
-8,922 Reduced 5.0%
169,518 $466,000
Q2 2022

Jul 27, 2022

SELL
$3.11 - $7.48 $86,706 - $208,542
-27,880 Reduced 13.51%
178,440 $557,000
Q1 2022

May 16, 2022

SELL
$4.88 - $8.56 $431,382 - $756,686
-88,398 Reduced 29.99%
206,320 $1.6 Million
Q4 2021

Feb 03, 2022

SELL
$7.03 - $13.03 $155,370 - $287,976
-22,101 Reduced 6.98%
294,718 $2.07 Million
Q3 2021

Oct 26, 2021

BUY
$11.11 - $17.84 $163,683 - $262,836
14,733 Added 4.88%
316,819 $3.58 Million
Q2 2021

Aug 12, 2021

BUY
$13.68 - $22.34 $3.54 Million - $5.79 Million
259,018 Added 601.42%
302,086 $5.46 Million
Q1 2021

May 11, 2021

BUY
$9.0 - $63.91 $115,236 - $818,303
12,804 Added 42.31%
43,068 $979,000
Q4 2020

Feb 04, 2021

BUY
$4.82 - $10.1 $28,052 - $58,782
5,820 Added 23.81%
30,264 $250,000
Q3 2020

Nov 13, 2020

BUY
$4.7 - $8.7 $21,883 - $40,507
4,656 Added 23.53%
24,444 $119,000
Q2 2020

Aug 10, 2020

BUY
$5.54 - $10.81 $6,448 - $12,582
1,164 Added 6.25%
19,788 $141,000
Q1 2020

May 15, 2020

BUY
$2.47 - $21.36 $5,750 - $49,726
2,328 Added 14.29%
18,624 $128,000
Q4 2019

Feb 12, 2020

BUY
$15.72 - $24.88 $91,490 - $144,801
5,820 Added 55.56%
16,296 $279,000
Q3 2019

Nov 13, 2019

BUY
$24.74 - $49.3 $259,176 - $516,466
10,476 New
10,476 $259,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $862M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Cambria Investment Management, L.P. Portfolio

Follow Cambria Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Cambria Investment Management, L.P. with notifications on news.